NR1H4 and fatty liver disease: These findings suggest that FXR deficiency is associated with a pro-inflammatory gut microbiota profile, emphasizing the role of gut microbiota in fatty liver disease pathogenesis and the potential therapeutic impact of puerarin in modulating these effects.